SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-22-128337
Filing Date
2022-12-20
Accepted
2022-12-19 17:32:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2232952d3_sc13g.htm SC 13G 56288
  Complete submission text file 0001104659-22-128337.txt   57563
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Subject) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92695 | Film No.: 221472205
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSCODE THERAPEUTICS 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address
Dudley Robert Michael (Filed by) CIK: 0001854161 (see all company filings)

Type: SC 13G